Recombinant MAPT (Posdinemab Biosimilar) antibody

Catalog No. ABIN7829325

The Humanized Monoclonal anti-MAPT (Posdinemab Biosimilar) antibody (ABIN7829325) specifically detects MAPT (Posdinemab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant MAPT (Posdinemab Biosimilar) antibody (ABIN7829325)

Target: MAPT (Posdinemab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This MAPT (Posdinemab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-MAPT (Posdinemab Biosimilar) Antibody

Purpose: Anti-MAPT(posdinemab biosimilar) mAb

Isotype: IgG1

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for MAPT (Posdinemab Biosimilar)

Target: MAPT (Posdinemab Biosimilar)

Alternative Name: Posdinemab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:TAU,FTD1,MSTD,PPND,DDPAC,MAPTL,MTBT1,MTBT2,tau-40,FTDP-17,PPP1R103,Tau-PHF6
Synonyms Antibody:JNJ-63733657,JNJ 63733657,JNJ63733657,JNJ-3657,JNJ3657,JNJ 3657

UniProt: P10636